Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care

NCT04362085 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

465

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Therapeutic Anticoagulation

Sponsor

Unity Health Toronto

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]